CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
7.97
-0.14 (-1.73%)
At close: Aug 15, 2025, 3:59 PM
7.89
-1.07%
After-hours: Aug 15, 2025, 07:49 PM EDT
-1.73% (1D)
| Bid | 7.89 |
| Market Cap | 9.53M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.9M |
| EPS (ttm) | -542.17 |
| PE Ratio (ttm) | -0.01 |
| Forward PE | -0.14 |
| Analyst | Buy |
| Ask | 8.1 |
| Volume | 27,844 |
| Avg. Volume (20D) | 1,125,336 |
| Open | 8.29 |
| Previous Close | 8.11 |
| Day's Range | 7.91 - 8.30 |
| 52-Week Range | 6.71 - 896.00 |
| Beta | 0.49 |
About CERO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CERO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CERO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+188.65%
CERo Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
+38.84%
CERo Therapeutics Holdings shares are trading higher after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.
